Cyclerion Therapeutics’ Sale of Medicine to Treat Mitochondrial Encephalopathy

Hughes Hubbard & Reed LLP represented Cyclerion Therapeutics in the deal.Cyclerion Therapeutics (NASDAQ: CYCN) announced the company’s sale of the rights to two drugs used to…

This content is for Standard 1 Year members only.
Login Join Now
Laura Testa

Author: Laura Testa

This content is for Standard 1 Year members only.
Login Join Now